首页> 美国卫生研究院文献>Pharmacy: Journal of Pharmacy Education and Practice >How Do Pharmacists Develop into Advanced Level Practitioners? Learning from the Experiences of Critical Care Pharmacists
【2h】

How Do Pharmacists Develop into Advanced Level Practitioners? Learning from the Experiences of Critical Care Pharmacists

机译:药剂师如何发展为高级从业人员?从重症监护药剂师的经验中学习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The national UK standards for critical care highlight the need for clinical pharmacists to practise at an advanced level (equivalent to Royal Pharmaceutical Society, Great Britain, Faculty Advanced Stage II (MFRPSII)) and above. Currently the UK is unable to meet the workforce capacity requirements set out in the national standards in terms of numbers of pharmacist working at advanced level and above. The aim of this study was to identify the strategies, barriers and challenges to achieving Advanced Level Practice (ALP) by learning from the experiences of advanced level critical care pharmacists within the UK. Eight participants were recruited to complete semi-structured interviews on their views and experiences of ALP. The interviews were analysed thematically and three overarching themes were identified; support, work-based learning and reflective practice. The results of this study highlight that to increase the number of MFRPSII level practitioners within critical care support for their ALP development is required. This support involves developing face-to-face access to expert critical care pharmacists within a national training programme. Additionally, chief pharmacists need to implement drivers including in house mentorship and peer review programmes and the need to align job descriptions and appraisals to the Royal Pharmaceutical Society, Great Britain, Advanced Practice Framework (APF).
机译:英国的重症监护国家标准强调了临床药剂师必须具有更高水平的执业资格(相当于英国皇家药学会,高级阶段II(MFRPSII))。目前,英国无法满足国家标准中对高级和以上水平的药剂师人数的要求。这项研究的目的是通过学习英国的高级重症监护药剂师的经验来确定实现高级实践(ALP)的策略,障碍和挑战。招募了八名参与者,以完成他们对ALP的看法和经验的半结构式访谈。对访谈进行了专题分析,确定了三个总体主题。支持,基于工作的学习和反思性实践。这项研究的结果强调,需要在重症监护支持中增加MFRPSII级从业人员的数量,以支持其ALP的发展。这种支持涉及在国家培训计划中与专家级重症护理药剂师进行面对面的交流。此外,首席药剂师需要实施包括内部指导和同行评审计划在内的驱动程序,并且需要使职务说明和评估与英国皇家药学会高级实践框架(APF)保持一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号